Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001076809-24-000125
Filing Date
2024-11-14
Accepted
2024-11-14 17:29:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 tvgn20240930.htm SC 13G/A 59775
  Complete submission text file 0001076809-24-000125.txt   61566
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

EIN.: 134032491 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Subject) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93039 | Film No.: 241464549
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)